Skip to main content
Apotheon
§ INJ-02·GLP-1 escalation · weekly SubQ

Semaglutide Dosage Chart & Calculator

Visual escalation for Ozempic and Wegovy, with tirzepatide (Mounjaro/Zepbound) and retatrutide side-by-side. Unit converter for compounded vials.

FDAapproved; Ozempic / Wegovy2.4 mgWegovy max · weekly3 drugsside-by-side comparison

§ UNIT CONVERTER

Injection volume for compounded semaglutide vials

For compounded semaglutide vials; enter your vial concentration and desired dose to calculate injection volume.

Inject: 0.5 mL (50 units on U-100 syringe)

§ CONTEXT

What the chart covers

This semaglutide dosage chart shows the standard dose escalation schedule for Ozempic (semaglutide for type 2 diabetes) and Wegovy (semaglutide for weight management). The side-by-side comparison includes tirzepatide (Mounjaro/Zepbound), a dual GIP/GLP-1 agonist, and retatrutide (LY3437943), Lilly's investigational triple GIP/GLP-1/glucagon agonist.

§ ReferencesFDA labels · TRIUMPH Phase 3 program · NEJM / Lancet trials
  1. 01Ozempic prescribing information
  2. 02Wegovy prescribing information
  3. 03Mounjaro prescribing information
  4. 04Jastreboff et al.; NEJM 2023 (Phase 2 obesity)
  5. 05Rosenstock et al.; Lancet 2023 (Phase 2 T2D)
  6. 06TRIUMPH Phase 3 design paper; Diabetes Obes Metab 2026

§ FAQ

Escalation, Ozempic vs Wegovy, side effects

Semaglutide (Wegovy) starts at 0.25 mg weekly for 4 weeks, then increases to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg weekly. Each escalation lasts 4 weeks. Ozempic follows the same initial steps but maxes at 1 mg (or 2 mg for some patients).

Private feedback · goes to the maintainer

Spotted a wrong number, a missing edge case, or a citation issue? Send it. Not published anywhere.

§ RELATED

Other calculators in the platform